Guaifenesin 51316-0071
Product NDC
51316-0071- Manufacturer
- Cvs
- Dosage Form
- Tablet, Extended Release
- Route
- Oral
- Product Type
- Human Otc Drug
- Marketing Start
- October 7, 2022
- Listing Expires
- December 31, 2026
- Application
- ANDA209254
Active Ingredients
| Ingredient | Strength |
|---|---|
| Guaifenesin | 600 mg/1 |
Drug Class
Expectorant [EPC]Decreased Respiratory Secretion Viscosity [PE]Expectorant [EPC]
Packaging Options(1)
1 BLISTER PACK in 1 CARTON (51316-071-68) / 68 TABLET, EXTENDED RELEASE in 1 BLISTER PACK